Recipient of federal assistance · DURHAM, NC

NEUROGT INC

NEUROGT INC received $3.2M in federal grants and other assistance in FY2026, on 8 actions, −23% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $10M. Its largest awarding agency was National Institutes of Health ($3.2M).

Assistance · FY2026
$3.2M
New awards
0
Actions
8
Since FY2021
$10M
UEI
NQHRNCAD21P3
Location
DURHAM, NC
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 284.4KFY2021
  2. 378.9KFY2022
  3. 630.3KFY2023
  4. 1.5MFY2024
  5. 4.1MFY2025
  6. 3.2MFY2026

By type

  1. Grants$3.2M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders$3.2M100%

Awarding agencies

  1. National Institutes of Health$3.2M100%
    Department of Health and Human Services

Largest awards

  1. DEVELOPMENT OF GENE THERAPY PRODUCT FOR TREATING MPS IIIB - PROJECT SUMMARY THE GOAL OF THIS FAST-TRACK SBIR PROJECT IS TO FURTHER DEVELOP…$3.1M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Aug 30, 2024 – Sep 14, 2026· R44NS135667
  2. TRANS-BBB AAV9 GENE THERAPY TARGETING CNS NEUROPATHY OF MPS I - PROJECT SUMMARY THE GOAL OF THIS PHASE II SBIR PROJECT IS TO FURTHER…$3M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Sep 16, 2025 – Sep 14, 2026· R44NS143501
  3. PROTEIN DEPLETING PRE-EXISTING ANTIBODIES FOR VIRAL GENE THERAPY - PROJECT SUMMARY: THIS IS A FAST-TRACK SBIR GRANT PROPOSAL. AS EFFECTIVE…$2.3M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Jul 27, 2023 – Jul 13, 2026· R44AI172670
  4. NOVEL AAV GENE THERAPY FOR TREATING CNS NEUROPATHY OF MPS IIIC - PROJECT SUMMARY MPS IIIC IS A DEVASTATING LYSOSOMAL STORAGE DISEASE (LSD)…$692.6K
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Jul 8, 2025 – May 12, 2026· R41NS143578

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.